JP2025504049A5 - - Google Patents

Info

Publication number
JP2025504049A5
JP2025504049A5 JP2024545047A JP2024545047A JP2025504049A5 JP 2025504049 A5 JP2025504049 A5 JP 2025504049A5 JP 2024545047 A JP2024545047 A JP 2024545047A JP 2024545047 A JP2024545047 A JP 2024545047A JP 2025504049 A5 JP2025504049 A5 JP 2025504049A5
Authority
JP
Japan
Prior art keywords
composition according
family
food
protease
subject
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024545047A
Other languages
English (en)
Japanese (ja)
Other versions
JP2025504049A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2023/061253 external-priority patent/WO2023147350A1/en
Publication of JP2025504049A publication Critical patent/JP2025504049A/ja
Publication of JP2025504049A5 publication Critical patent/JP2025504049A5/ja
Pending legal-status Critical Current

Links

JP2024545047A 2022-01-26 2023-01-25 血糖安定化方法及び組成物 Pending JP2025504049A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202263303112P 2022-01-26 2022-01-26
US63/303,112 2022-01-26
PCT/US2023/061253 WO2023147350A1 (en) 2022-01-26 2023-01-25 Blood glucose stabilizing methods and compositions

Publications (2)

Publication Number Publication Date
JP2025504049A JP2025504049A (ja) 2025-02-06
JP2025504049A5 true JP2025504049A5 (https=) 2025-05-28

Family

ID=87472642

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024545047A Pending JP2025504049A (ja) 2022-01-26 2023-01-25 血糖安定化方法及び組成物

Country Status (8)

Country Link
US (4) US11821013B2 (https=)
EP (1) EP4469075A4 (https=)
JP (1) JP2025504049A (https=)
KR (1) KR20250008727A (https=)
AU (2) AU2023213894B2 (https=)
CA (1) CA3250056A1 (https=)
MX (1) MX2024009289A (https=)
WO (1) WO2023147350A1 (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4469075A4 (en) 2022-01-26 2025-09-10 Digestiva Inc METHODS AND COMPOSITIONS FOR STABILIZING BLOOD GLUCOSE
EP4709834A1 (en) * 2023-05-11 2026-03-18 Digestiva, Inc. Wine dehazing methods and compositions

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3097145A (en) 1962-03-30 1963-07-09 Takeda Chemical Industries Ltd Acid protease and the production thereof
JPH05244957A (ja) 1991-10-04 1993-09-24 Suntory Ltd シュードモナス属細菌由来ペプスタチン非感受性酸性プロテアーゼ遺伝子
US6302685B1 (en) 1997-09-16 2001-10-16 University Of Medicine And Dentistry Of New Jersey Human lysosomal protein and methods of its use
JP2002078489A (ja) 2000-09-04 2002-03-19 Daiwa Kasei Kk セリン残基が活性発現に関与する新規酸性プロテアーゼ
US20040142325A1 (en) 2001-09-14 2004-07-22 Liat Mintz Methods and systems for annotating biomolecular sequences
US7320788B2 (en) 2002-02-14 2008-01-22 The Board Of Trustees Of The Leland Stanford Junior University Enzyme treatment of foodstuffs for Celiac Sprue
EP1685764A1 (en) 2005-01-27 2006-08-02 Globus Egg Sciences B.V. Anti-hypertensive functional food products
RU2446210C2 (ru) 2006-02-02 2012-03-27 ДСМ АйПи АССЕТС Б.В. Пищевой продукт, содержащий специфичную к пролину протеазу, способ его производства и его применение для расщепления токсичных или аллергенных пептидов глютена
CN101455368B (zh) 2008-12-29 2012-06-27 陕西天宝大豆食品技术研究所 杏仁肽营养品及其制备方法
WO2011125015A2 (en) 2010-04-05 2011-10-13 Bar-Ilan University Protease-activatable pore-forming polypeptides
US20130034530A1 (en) 2011-04-29 2013-02-07 David R. Fantz Dietary Supplement Cognitive Support System
CA2882502A1 (en) 2011-08-10 2013-02-14 University Of Washington Through Its Center For Commercialization Compositions and methods for treating celiac sprue disease
US20130156884A1 (en) 2011-12-19 2013-06-20 Triarco Industries Protease enzymes for increased protein digestion rate and absorption and methods of using the same
AU2013311668B2 (en) * 2012-09-05 2019-02-28 Novozymes A/S Polypeptides having protease activity
US10266815B2 (en) 2013-08-14 2019-04-23 University Of Washington Through Its Center For Commercialization Compositions and methods for treating celiac sprue disease
CN106191183B (zh) 2015-05-04 2019-11-29 浙江海正药业股份有限公司 西兰花蛋白肽的制备方法及其应用
BE1023038B1 (fr) 2015-06-12 2016-11-09 Proteifood Sa Produit alimentaire expanse sec a base de proteine et son procede de fabrication
CA3013383A1 (en) * 2016-02-25 2017-08-31 Dupont Nutrition Biosciences Aps Method for producing a protein hydrolysate employing an aspergillus fumigatus tripeptidyl peptidase
ES3039968T3 (en) * 2016-06-23 2025-10-28 Ew Nutrition Gmbh Feed composition comprising an acid protease
AU2017380106B2 (en) 2016-12-22 2024-05-09 Ew Nutrition Gmbh Stable protease variants
WO2020087017A1 (en) * 2018-10-26 2020-04-30 The Regents Of The University Of California Use of proteolytic enzymes to enhance protein bioavailability
EP4469075A4 (en) 2022-01-26 2025-09-10 Digestiva Inc METHODS AND COMPOSITIONS FOR STABILIZING BLOOD GLUCOSE

Similar Documents

Publication Publication Date Title
US8975223B2 (en) Methods for treating metabolic disorders and obesity with a peptide comprising the amino acid sequence of SEQ ID No. 146
JP5669395B2 (ja) 新規化合物および摂食行動に対するその効果
US12059454B2 (en) Oral delivery of angiotensin converting enzyme 2 (ACE2) or angiotensin-(1-7)-bioencapsulated in plant cells attenuates pulmonary hypertension, cardiac dysfunction and development of autoimmune and experimentally induced ocular disorders
TWI619724B (zh) 新穎之調酸素衍生物及含有該衍生物之用於治療肥胖之醫藥組成物
US20040115135A1 (en) Compositions and methods for enhanced mucosal delivery of peptide YY and methods for treating and preventing obesity
JP2025504049A5 (https=)
AU2014324900A1 (en) Compositions and formulations for prevention and reduction of tumorigenesis, cancer cell proliferation and invasion, and methods of production and use thereof in cancer treatment
JPWO2017010538A1 (ja) 動植物由来ペプチド含有血清カルノシン分解酵素阻害用組成物
JP2011182742A (ja) 血中ジペプチジルペプチダーゼ−ｉｖ阻害活性およびグルカゴン様ペプチド−１の分泌促進活性を併せ持つ組成物
KR100996985B1 (ko) 글루카곤양 펩티드-１ 분비 촉진제, 글루카곤양 펩티드-１분비 촉진용 음식품, 식후 혈당값 상승 억제제 및 식후혈당값 상승 억제용 음식품
JP3691685B2 (ja) 血糖値上昇抑制剤
JP6829186B2 (ja) 海産物ペプチドおよび魚類ヌクレオチド、その組成物および血糖を低下させるためのその使用
WO2018188565A1 (zh) 用于治疗代谢系统疾病的多肽及其组合物
JP2016164136A (ja) 鰹節由来のジペプチジルペプチダーゼｉｖ阻害組成物
JP2019043871A (ja) 血中尿酸値低減剤及び血中尿酸値低減用組成物
US20090082283A1 (en) Dipeptides for Prevention of Muscle Breakdown and Microbial Infection
JP7250290B2 (ja) 栄養補給欲促進剤
TW201238972A (en) Methods for treating metabolic disorders and obesity with GIP and GLP-1 receptor-active glucagon-based peptides
KR101689803B1 (ko) 아펠린-16을 유효성분으로 함유하는 당뇨 또는 비만의 예방 또는 치료용 조성물
WO2026085450A1 (en) Pharmaceutical compositions for direct systemic introduction
JP2013082658A (ja) 経口投与により食欲を抑制する素材
JP2021528424A (ja) 対象における食後のグルコースレベルをコントロールする方法および使用
WO2006085523A1 (ja) 血糖値上昇抑制用組成物
AU2009238272A1 (en) Method of treatment of diabetes type 2 comprising add-on therapy to metformin
HK1120440B (en) Agent for promoting glucagon-like peptide 1 secretion, food or drink for promoting glucagon-like peptide 1 secretion, agent for inhibiting postprandial increase in blood sugar level and food or drink for inhibiting postprandial increase in blood sugar level